Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 16
1994 55
1995 95
1996 68
1997 88
1998 54
1999 58
2000 46
2001 68
2002 42
2003 49
2004 52
2005 58
2006 46
2007 46
2008 49
2009 68
2010 83
2011 84
2012 121
2013 118
2014 124
2015 176
2016 189
2017 201
2018 235
2019 154
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

2,228 results
Results by year
Filters applied: . Clear all
Page 1
The making of bispecific antibodies.
Brinkmann U, Kontermann RE. Brinkmann U, et al. MAbs. 2017 Feb/Mar;9(2):182-212. doi: 10.1080/19420862.2016.1268307. MAbs. 2017. PMID: 28071970 Free PMC article. Review.
Bispecific antibodies for cancer therapy: A review.
Krishnamurthy A, Jimeno A. Krishnamurthy A, et al. Pharmacol Ther. 2018 May;185:122-134. doi: 10.1016/j.pharmthera.2017.12.002. Epub 2017 Dec 18. Pharmacol Ther. 2018. PMID: 29269044 Review.
Bispecific antibodies: a mechanistic review of the pipeline.
Labrijn AF, Janmaat ML, Reichert JM, Parren PWHI. Labrijn AF, et al. Nat Rev Drug Discov. 2019 Aug;18(8):585-608. doi: 10.1038/s41573-019-0028-1. Nat Rev Drug Discov. 2019. PMID: 31175342 Review.
Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia.
Guy DG, Uy GL. Guy DG, et al. Curr Hematol Malig Rep. 2018 Dec;13(6):417-425. doi: 10.1007/s11899-018-0472-8. Curr Hematol Malig Rep. 2018. PMID: 30280288 Free PMC article. Review.
Bispecific antibodies: design, therapy, perspectives.
Sedykh SE, Prinz VV, Buneva VN, Nevinsky GA. Sedykh SE, et al. Drug Des Devel Ther. 2018 Jan 22;12:195-208. doi: 10.2147/DDDT.S151282. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29403265 Free PMC article. Review.
Engineering therapeutic bispecific antibodies using CrossMab technology.
Klein C, Schaefer W, Regula JT, Dumontet C, Brinkmann U, Bacac M, UmaƱa P. Klein C, et al. Methods. 2019 Feb 1;154:21-31. doi: 10.1016/j.ymeth.2018.11.008. Epub 2018 Nov 16. Methods. 2019. PMID: 30453028 Free article. Review.
Bispecific antibodies in haematological malignancies.
Viardot A, Bargou R. Viardot A, et al. Cancer Treat Rev. 2018 Apr;65:87-95. doi: 10.1016/j.ctrv.2018.04.002. Epub 2018 Apr 4. Cancer Treat Rev. 2018. PMID: 29635163 Review.
Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation.
Correnti CE, Laszlo GS, de van der Schueren WJ, Godwin CD, Bandaranayake A, Busch MA, Gudgeon CJ, Bates OM, Olson JM, Mehlin C, Walter RB. Correnti CE, et al. Leukemia. 2018 May;32(5):1239-1243. doi: 10.1038/s41375-018-0014-3. Epub 2018 Jan 31. Leukemia. 2018. PMID: 29588544 Free PMC article. No abstract available.
2,228 results
Jump to page
Feedback